Showing results (111-120 of 6,853) with videos related to
Sort By:
Pageof 686
Journal of Comparative Effectiveness Research|November 17, 2017
Gene therapy: evidence, value and affordability in the US health care systemGrace Hampson, Adrian Towse, Steven D Pearson, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 22, 2005
Variability of cost-effectiveness estimates for pharmaceuticals in Western Europe: lessons for inferring generalizabilityMarco Barbieri, Michael Drummond, Richard Willke, et al.Journal of Comparative Effectiveness Research|November 15, 2018
A framework to guide the optimal development and use of real-world evidence for drug coverage and formulary decisionsSteven D Pearson, William B Dreitlein, Adrian Towse, et al.Journal of Comparative Effectiveness Research|November 10, 2018
Real-world evidence for coverage decisions: opportunities and challengesGrace Hampson, Adrian Towse, William B Dreitlein, et al.Acta Orthopaedica|January 30, 2024
The risk of revision is higher following shoulder hemiarthroplasty compared with total shoulder arthroplasty for osteoarthritis: a matched cohort study of 11,556 patients from the National Joint Registry, UKAndrew R Davies, Sanjeeve Sabharwal, Alexander D Liddle, et al.Journal of Pain & Palliative Care Pharmacotherapy|December 21, 2017
Prevalence of and Comorbid Health Conditions Associated With Pediatric Prescription Opioid Use in the USSouvik Banerjee, Carl L Roland, Richard Willke, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 26, 2018
An Overview of Value, Perspective, and Decision Context-A Health Economics Approach: An ISPOR Special Task Force Report [2]Louis P Garrison, Mark V Pauly, Richard J Willke, et al.American Journal of Medical Genetics. Part C, Seminars in Medical Genetics|March 1, 2023
A review of economic issues for gene-targeted therapies: Value, affordability, and accessLouis P Garrison, Andrew W Lo, Richard S Finkel, et al.BMC Medicine|January 29, 2024
Is the price right? Paying for value today to get more value tomorrowSreeram V Ramagopalan, Jose Diaz, Grace Mitchell, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|July 24, 2008
The potential clinical and economic outcomes of pharmacogenomic approaches to EGFR-tyrosine kinase inhibitor therapy in non-small-cell lung cancerJosh J Carlson, Louis P Garrison, Scott D Ramsey, et al.Pageof 686